DeepSeek’s breakthrough AI model has kept the AI industry buzzing these past two weeks, sending stocks of big names in tech plummeting. However, there is one sector that leverages AI but is not susceptible to its volatility, and that is healthcare tech.

Health care tech benefits from advancements in AI while sidestepping the megacap tech names that often dominate portfolios. Plus, valuations in health care have relaxed, adding to the positives. Here are three ETFs that stand out, avoiding concentration risk while providing exposure to cutting-edge tech:

ROBO Global Healthcare Technology and Innovation ETF HTEC: This ETF charges 68 basis points in fees and covers a broad range of industries, including regenerative medicine, lab process automation, and telehealth.

Also Read: Meta Vs. Microsoft: Can Their AI Infrastructure Plans Hold Up Against DeepSeek?

Global X Telemedicine & Digital Health ETF EDOC offers another way to capitalize on the rapid digital transformation in health care. As the demand for telehealth, AI-driven diagnostics, and remote patient monitoring accelerates, this ETF provides targeted exposure.

According to Precedence Research, the global health care IT market is expected to be valued at $880.56 billion in 2025 and is expected to reach $3.3 trillion by 2034, witnessing a CAGR of 15.83%. EDOC's holdings include firms developing AI-powered radiology tools, medical imaging solutions, and drug discovery platforms.

Moreover, the ETF stands to benefit from the increased adoption of natural language processing (NLP) systems, an AI innovation that enhances doctor-patient interactions and streamlines administrative workflows. These innovations help reduce paperwork and improve efficiency, which are key factors driving industry-wide growth.

iShares U.S. Medical Devices ETF IHI is best suited for investors looking for a more hardware-focused approach. This ETF offers exposure to leading medical technology companies. This ETF targets firms specializing in robotic-assisted surgery, diagnostic imaging, and medical instruments.

As of early 2025, the U.S. health care technology management market is projected to reach $17.3 billion by 2028, growing at a robust CAGR of 15.6%, per Markets and Markets.

This ETF also carries an expense ratio of 0.68%, and is well-positioned to benefit from AI's role in surgical precision, automation, and predictive analytics.

Read Next:

• Telecom ETFs Gain Momentum As Sector Giants AT&T, Verizon, T-Mobile Reinforce Investor Confidence

Photo: raker/Shutterstock.com